Viewing Study NCT05222802


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:01 AM
Study NCT ID: NCT05222802
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2022-01-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
Sponsor: Katmai Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module